Tilray Brands
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Tilray Brands and other ETFs, options, and stocks.About TLRY
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness.
CEOIrwin David Simon
CEOIrwin David Simon
Employees2,842
Employees2,842
HeadquartersLeamington, Ontario
HeadquartersLeamington, Ontario
Founded2018
Founded2018
Employees2,842
Employees2,842
TLRY Key Statistics
Market cap1.05B
Market cap1.05B
Price-Earnings ratio-0.41
Price-Earnings ratio-0.41
Dividend yield—
Dividend yield—
Average volume25.15M
Average volume25.15M
High today$9.55
High today$9.55
Low today$8.95
Low today$8.95
Open price$9.23
Open price$9.23
Volume6.78M
Volume6.78M
52 Week high$23.20
52 Week high$23.20
52 Week low$3.51
52 Week low$3.51
Stock Snapshot
With a market cap of 1.05B, Tilray Brands(TLRY) trades at $8.98. The stock has a price-to-earnings ratio of -0.41.
On 2025-12-30, Tilray Brands(TLRY) stock moved within a range of $8.95 to $9.55. With shares now at $8.98, the stock is trading +0.3% above its intraday low and -6.0% below the session's peak.
Trading volume for Tilray Brands(TLRY) stock has reached 6.78M, versus its average volume of 25.15M.
The stock's 52-week range extends from a low of $3.51 to a high of $23.20.
The stock's 52-week range extends from a low of $3.51 to a high of $23.20.
TLRY News
Nasdaq 7d
This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch NextKey Points Tilray's shares have soared since mid-2025, driven by expectations of cannabis reclassification in the U.S. These expectations have now become a re...
Analyst ratings
64%
of 11 ratingsBuy
36.4%
Hold
63.6%
Sell
0%
People also own
Based on the portfolios of people who own TLRY. This list is generated using Robinhood data, and it’s not a recommendation.